Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

Sussex County Prosecutor's Office
Dec. 7Justin Metcalf, 29, of Vernon, was sentenced to 18 months in New Jersey State Prison. He was ordered to submit a DNA sample and pay...
Read more »

Assembly frenzy comes to Selective
There's an annual event at Selective Insurance that's become a highly-anticipated competition.
Groups from different...

Read more »
Image

Wallkill Valley artists win big at art show
Hundreds of people braved the cold weather Friday night to attend the 8th annual Wallkill Valley Invitational Art Show.
Read more »
Image

Rotary honored

Read more »
Image

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers



MOST READ

Entertainment
Library to host 'War of the Worlds'
  • Dec 4, 2018
Entertainment
James Hunter coming to Newton
  • Dec 4, 2018

MOST COMMENTED



Find more about Weather in Lafayette, NJ